Eversept Partners’s R1 RCM Inc. Common Stock RCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-590,819
Closed -$12.4M – 87
2022
Q2
$12.4M Sell
590,819
-770,687
-57% -$17.5M 0.88% 32
2022
Q1
$36.4M Buy
1,361,506
+628,374
+86% +$15.4M 2.8% 13
2021
Q4
$18.7M Sell
733,132
-31,648
-4% -$759K 1.19% 23
2021
Q3
$16.8M Sell
764,780
-5,220
-0.7% -$108K 1.16% 24
2021
Q2
$17.1M Buy
+770,000
New +$18.6M 1.14% 27
2020
Q1
– Sell
-416,726
Closed -$5.41M – 80
2019
Q4
$5.41M Sell
416,726
-309,246
-43% -$3.53M 0.96% 29
2019
Q3
$6.48M Sell
725,972
-1,973,187
-73% -$23.3M 2.01% 15
2019
Q2
$34M Sell
2,699,159
-264,500
-9% -$2.99M 9.51% 1
2019
Q1
$28.7M Buy
2,963,659
+614,353
+26% +$5.56M 8.36% 3
2018
Q4
$18.7M Buy
2,349,306
+664,219
+39% +$5.74M 10.11% 3
2018
Q3
$17.1M Sell
1,685,087
-122,989
-7% -$1.12M 7.51% 3
2018
Q2
$15.7M Sell
1,808,076
-101,811
-5% -$824K 7.18% 2
2018
Q1
$13.6M Buy
1,909,887
+268,009
+16% +$1.51M 6.33% 3
2017
Q4
$7.24M Buy
+1,641,878
New +$6.42M 4.17% 8

Other funds holding RCM

Eversept Partners's RCM Position: Q3 2022 in Review

Eversept Partners sold out of R1 RCM Inc. Common Stock (RCM) in Q3 2022, closing a stake of 590,819 shares — an estimated $12.4M sold.

Eversept Partners first reported a position in RCM in Q4 2017 and held it in 14 quarters. The position peaked at $36.4M in Q1 2022. 246 funds tracked by Wall St. Rank hold RCM as of Q3 2022.

  • Eversept Partners reported no remaining R1 RCM Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Eversept Partners sold 590,819 R1 RCM Inc. Common Stock shares in Q3 2022, an estimated $12.4M.
  • Eversept Partners first reported a position in R1 RCM Inc. Common Stock in Q4 2017 and held it in 14 quarters.
  • Eversept Partners's R1 RCM Inc. Common Stock position peaked at $36.4M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held R1 RCM Inc. Common Stock as of Q3 2022.

Based on Eversept Partners's 13F filing for Q3 2022, filed 14 Nov 2022.